Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Nanoscale DNA Cages for Directed Delivery of Small Drug Compounds

By BiotechDaily International staff writers
Posted on 12 Sep 2013
Image: A DNA cage (at left), with lipid-like molecules (in blue). The lipids come together in a "handshake" within the cage (center image) to encapsulate small-molecule drugs (purple). The molecules are released (at right) in response to the presence of a specific nucleic acid (Photo courtesy of Thomas Edwardson, McGill University).
Image: A DNA cage (at left), with lipid-like molecules (in blue). The lipids come together in a "handshake" within the cage (center image) to encapsulate small-molecule drugs (purple). The molecules are released (at right) in response to the presence of a specific nucleic acid (Photo courtesy of Thomas Edwardson, McGill University).
A novel method for directed drug delivery is based on enclosing low molecular weight compounds in nanoscale "cages" built of DNA strands that sequester the compound until contact with a specific nucleic acid sequence triggers release of the drug.

Investigators at McGill University (Montreal, Canada) had shown previously that drugs could be loaded into gold nanoparticles that could be inserted and released from DNA nanotubes. In the current study, they greatly reduced the size of the carrier DNA constructs. Highly branched alkyl-DNA conjugates were hybridized to the edges of a DNA cube. When four amphiphiles were on one face, the hydrophobic residues of two neighboring cubes engaged in an intermolecular "handshake,” resulting in a dimer. When there were eight amphiphiles (four on the top and bottom cube faces, respectively), they engaged in an intramolecular "handshake" inside the cube. The DNA cube thus surrounded a lipid-like space into which small molecule compounds could be loaded.

Details of the construction and testing of DNA "nanocages" were published in the September 1, 2013, online edition of the journal Nature Chemistry. This paper described the creation of a three-dimensional pattern of hydrophobic patches, like side chains in proteins, which resulted in the specific, directed association of hydrophobic domains with orthogonal interactions to DNA base pairing. This formed the first example of a monodisperse micelle within a DNA nanostructure that encapsulated small molecules and released them by DNA recognition.

"This research is important for drug delivery, but also for fundamental structural biology and nanotechnology," said senior author Dr. Hanadi Sleiman, professor of chemistry at McGill University.

The investigators are now conducting cell and animal studies to assess the viability of this method on chronic lymphocytic leukemia (CLL) and prostate cancer.

Related Links:

McGill University



comments powered by Disqus

Channels

Drug Discovery

view channel

Ibuprofen May Restore Immune Function in Older Individuals

New research suggests that macrophages from the lungs of old mice respond differently to infections than those of young mice, and ibuprofen given to the mice reversed these changes. New research using lab mice suggests that the solution to more youthful immune function might already be a common over-the-counter pain reliever.... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Lab Technologies

view channel
Image: Leica Microsystems launches the inverted research microscope platform Leica DMi8 (Photo courtesy of Leica Microsystems).

New Inverted Microscope Designed to Readily Adapt to Changing Research Demands

A new inverted microscope for biotech and other life science laboratories was designed to readily accommodate modifications and upgrades to allow it to keep current with changing research demands and interests.... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.